PolyPid (PYPD) Common Equity (2019 - 2026)
PolyPid's Common Equity was $5.39 million in Q2 2026, down 73.7% from $20.48 million a year earlier and down 38.6% from the prior quarter.
Powered by 
Analysis
PolyPid (PYPD) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at PolyPid came in at $10.97 million, up 42.8% from FY2024.
- Common Equity shows a five-year compound annual growth rate of -31.5% (FY2020 to FY2025).
- In earlier years, Common Equity was $7.68 million in FY2024, -$2.1 million in FY2023, $5.83 million in FY2022 (-83.8%) and $35.96 million in FY2021 (-50.6%).
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q1 2025.
- Compared with a year earlier, Common Equity was higher in two of the last five quarters, with growth averaging 88.7%.
- The best year-over-year quarter for Common Equity over five years was Q3 2025 (growth of 612.0%); the worst was Q1 2025 (a decline of 98.8%).
- Per Business Quant data, PYPD's Common Equity in the three quarters before Q2 2026 was $8.78 million (Q1 2026), $10.97 million (Q4 2025) and $15.37 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | PolyPid | 96.66 Mn | 47.47 Mn | - | 5.39 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.39 Mn |
| Mar 31, 2026 | 8.78 Mn |
| Dec 31, 2025 | 10.97 Mn |
| Sep 30, 2025 | 15.37 Mn |
| Jun 30, 2025 | 20.48 Mn |
| Mar 31, 2025 | 86,000.00 |
| Dec 31, 2024 | 7.68 Mn |
| Sep 30, 2024 | 2.16 Mn |
| Jun 30, 2024 | 1.60 Mn |
| Mar 31, 2024 | 7.15 Mn |
| Dec 31, 2023 | -2.10 Mn |
| Sep 30, 2023 | 3.54 Mn |
| Jun 30, 2023 | 8.35 Mn |
| Mar 31, 2023 | 11.41 Mn |
| Dec 31, 2022 | 5.83 Mn |
| Sep 30, 2022 | 11.50 Mn |
| Jun 30, 2022 | 19.11 Mn |
| Mar 31, 2022 | 28.85 Mn |
| Dec 31, 2021 | 35.96 Mn |
| Sep 30, 2021 | 48.12 Mn |
API Access
PolyPid Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PYPD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PYPD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PYPD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();